Genetic Analysis (GEAN) | Spotlight

Home

Genetic Analysis is active in medical technology. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-: 0.05
%: 0,49%
Latest: 10.3
High: 10.5
Low: 9.9
Volume: 120 238
Turnover (NOK): 1 227 267
Value (MNOK): 256,6

Board

CEO

Ronny Hermansen

Chairperson of the Board

Kathryn Baker

Board

Ashok Shah
Camilla Huse Bondesson
Rune Sørum
Staffan Strömberg

News

2021-10-19 08:43:50 Genetic Analysis enters a Service Agreement with Eurofins ADME BIOANALYSES – The first CRO to offer the GA-map® Microbiome test
2021-10-14 08:46:22 Genetic Analysis receives important patent allowance in China
2021-10-05 14:51:25 Microbiome Dx Genetic Analysis raises USD 6.8 M in IPO
2021-10-01 08:00:00 Genetic Analysis AS (GEAN): First day of trading in Genetic Analysis shares and warrants on Spotlight Stock Market
2021-09-27 11:48:58 Spotlight: Market Notice 199/21 – Genetic Analysis AS will be listed on Spotlight Stock Market on October 1, 2021

Show More

News agencies

2021-10-19 08:58:34 Finwire: Genetic Analysis ingår serviceavtal med kontraktsforskningsorganisation
2021-10-14 09:04:34 Finwire: Genetic Analysis erhåller patent i Kina
2021-10-01 09:59:30 Direkt: INTERVJU MED VD OCH MARKNADSCHEF
2021-10-01 09:44:35 Finwire: Genetic Analysis klättrar 47 procent i premiärhandeln på Spotlight
2021-10-01 08:15:12 Direkt: MIKROBIOM OCH SJUKDOM I SIN LINDA-GENETIC ANALYSIS VD(OMS)

Show More

Upcoming reports

2021-11-09 Delårsrapport 2021-Q3

Annual reports, prospectus etc.